Since altered ER function could have impact on the risk of endometrial cancer, the estrogen receptor alpha gene (ESR1) is a plausible endometrial cancer candidate gene which has been investigated in a few studies [4-6]. This evidence concerns the gene ESR1 and endometrial cancer.